RPG Life Sciences Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|
| Revenue | 167.79 | 128.64 | 155.62 |
| Operating Expense | 126.35 | 106.27 | 115.80 |
| Net Profit | 26.76 | 13.24 | 26.46 |
| Net Profit Margin | 15.95 | 10.29 | 17.00 |
| Earning Per Share | 16.18 | 8.01 | 16 |
| EBIDTA | 41.71 | 23.32 | 40.24 |
| Effective Tax Rate | 22.95 | 24.36 | 23.86 |
| Particulars | Jun 2024 |
|---|---|
| Revenue | 167.79 |
| Operating Expense | 126.35 |
| Net Profit | 26.76 |
| Net Profit Margin | 15.95 |
| Earning Per Share | 16.18 |
| EBIDTA | 41.71 |
| Effective Tax Rate | 22.95 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 582.05 | 512.81 | 440.16 |
| Operating Expenses Annual | 453.90 | 410.12 | 353.80 |
| Operating Profit Annual | 135.36 | 107.49 | 89.35 |
| Interest Annual | 0.45 | 0.31 | 0.52 |
| Depreciation | 10.41 | 8.71 | 8.83 |
| Net Profit Annual | 87.66 | 67.64 | 51.48 |
| Tax Annual | 30.18 | 24.04 | 21.69 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 582.05 |
| Operating Expenses Annual | 453.90 |
| Operating Profit Annual | 135.36 |
| Interest Annual | 0.45 |
| Depreciation | 10.41 |
| Net Profit Annual | 87.66 |
| Tax Annual | 30.18 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 24.82 | 56.94 | 40.36 |
| Cash Flow from Operations | 94.36 | 90.82 | 64.75 |
| Cash Flow from Investing | -79.15 | -105.81 | -34.66 |
| Cash Flow from Financing | -20.31 | -17.12 | -13.51 |
| Cash Flow at the End | 19.72 | 24.83 | 56.94 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 24.82 |
| Cash Flow from Operations | 94.36 |
| Cash Flow from Investing | -79.15 |
| Cash Flow from Financing | -20.31 |
| Cash Flow at the End | 19.72 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 23.43 | 21.12 | 20.50 |
| PBIT Margin (%) | 20.49 | 18.10 | 16.94 |
| PBT Margin (%) | 6.26 | 2.36 | 4.92 |
| Net PROFIT Margin (%) | 15.06 | 13.19 | 11.70 |
| Return On Networth / Equity (%) | 25.69 | 24.01 | 21.80 |
| Return On Networth /Employed (%) | 34.25 | 32.15 | 30.57 |
| Return On Assets (%) | 25.15 | 23.48 | 21.05 |
| Total Debt / Equity (X) | TBA | TBA | 0.01 |
| Asset Turnover Ratio (%) | 1.67 | 1.78 | 1.80 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 23.43 |
| PBIT Margin (%) | 20.49 |
| PBT Margin (%) | 6.26 |
| Net PROFIT Margin (%) | 15.06 |
| Return On Networth / Equity (%) | 25.69 |
| Return On Networth /Employed (%) | 34.25 |
| Return On Assets (%) | 25.15 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 1.67 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 125.06 | 134.67 | 109.32 |
| Total Current Assets Annual | 298.09 | 264.05 | 206.91 |
| Non Current Assets Annual | 214.78 | 155.30 | 137.70 |
| Total Shareholders Funds Annual | 374.85 | 307.60 | 255.77 |
| Total Assets Annual | 512.87 | 419.35 | 344.61 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 125.06 |
| Total Current Assets Annual | 298.09 |
| Non Current Assets Annual | 214.78 |
| Total Shareholders Funds Annual | 374.85 |
| Total Assets Annual | 512.87 |
No Data Availabe
